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Background. Off-pump coronary artery bypass graft surgery (OPCAB) is still associated with
a marked systemic inflammatory response. The aim of this study was to investigate whether
pre-emptive, low dose of ketamine, which has been reported to have anti-inflammatory activity
in on-pump coronary artery bypass surgery, could reduce inflammatory response in low-risk
patients undergoing OPCAB.
Methods. In this prospective randomized-controlled trial, 50 patients with stable angina and
preserved myocardial function undergoing OPCAB were randomly assigned to receive either
0.5 mg kg21 of ketamine (Ketamine group, n¼25) or normal saline (Control group, n¼25) during
induction of anaesthesia. Inflammatory markers including C-reactive protein (CRP), interleukin
(IL)-6, tumour necrosis factor-a (TNF-a), and cardiac enzymes were measured previous to induc-
tion (T1), 4 h after surgery (T2), and the first and second days after the surgery (T3 and T4).
Results. There were no significant intergroup differences in the serum concentrations of the CRP,
IL-6, and TNF-a and cardiac enzymes. Pro-inflammatory markers and cardiac enzymes, except
TNF-a, were all increased after the surgery compared with baseline values in both groups.
Conclusions. Low-dose ketamine administered during anaesthesia induction did not exert
any evident anti-inflammatory effect in terms of reducing the serum concentrations of
pro-inflammatory markers in low-risk patients undergoing OPCAB.
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In cardiac surgery, the degree of systemic inflammatory
response is closely associated with patient’s outcome.1–3
Considering that cardiopulmonary bypass (CPB) and the
accompanied global myocardial ischaemia–reperfusion
injury are the main inciting causes of this inflammatory
response,4 off-pump coronary artery bypass graft surgery
(OPCAB) would confer different impact on the degree of
inflammatory reaction. Despite the theoretical advantage,
however, OPCAB also elicits marked systemic inflamma-
tory response,5 6 even to a similar degree as in on-pump
coronary artery bypass graft surgery (CABG).7–9
Inflammatory reaction, together with perturbation of the
haemostatic prothrombotic system, might play a substantial
role in developing adverse cardiovascular events in
OPCAB.6 Therefore, therapeutic strategies to counteract
the systemic inflammatory activation in OPCAB should be
considered.
Ketamine is an i.v. anaesthetic agent demonstrating
anti-inflammatory effect in various studies.10–12
Anti-inflammatory effect of low-dose ketamine has been
demonstrated mainly as a significant reduction in the
activity of pro-inflammatory mediators such as C-reactive
protein (CRP) and interleukin (IL)-6 in cardiac surgery
using CPB.11 13 Thus, we evaluated whether low dose of
ketamine administered during induction of anaesthesia
could reduce the activity of pro-inflammatory mediators in
low-risk patients undergoing OPCAB in a prospective, ran-
domized and controlled trial.
Methods
After institutional review board approval and patients’
consents, 50 patients undergoing elective, isolated multi-
vessel OPCAB between March 2007 and August 2007
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were studied. Patients were excluded, if they met one of
the following criteria: age 75 yr, recent (,14 days) myo-
cardial infarction, unstable angina with elevated creatine
kinase-MB (CK-MB), elevated serum creatinine (.1.3 mg
dl21) before operation, left ventricular ejection fraction
(LVEF) ,40%, previous cardiac surgery, previous stroke
or pulmonary disease, and history of treatment with steroid
or non-steroidal anti-inflammatory drugs within a month.
Emergency operations were also excluded.
Using a computer-generated randomization method,
patients were randomly assigned to receive either a bolus
of ketamine 0.5 mg kg21 (Ketamine group, n¼25) or
normal saline (Control group, n¼25) during induction of
anaesthesia. Being a double-blinded study, patients, anaes-
thetic provider, and anaesthetist collecting data were
blinded to the study group, and ketamine or normal saline
was prepared by an independent researcher in equal
volumes in 10 ml syringes.
All preoperative medications except diuretics and antipla-
telet agents were continued until the morning of surgery.
Patients were premedicated with i.m. morphine 0.05–0.1
mg kg21 1 h before anaesthesia. Upon arrival at the operat-
ing theatre, five ECG leads were attached, and leads II and
V5 were continuously monitored. A 20 G radial artery cath-
eter was inserted to monitor arterial pressure. A thermodilu-
tion pulmonary artery catheter (Swan-Ganz CCOmbow
CCO/SvO2; Edwards Lifesciences, Irvine, CA, USA) was
inserted into the right internal jugular vein before induction
of anaesthesia. Anaesthesia was induced with midazolam
0.03–0.05 mg kg21 after ketamine 1% (0.5 mg kg21) or
the same volume of normal saline, according to randomiz-
ation. After that, sufentanil 1.5–2.0 mg kg21 and rocuro-
nium bromide 50 mg were administered and tracheal
intubation was performed. Anaesthesia and neuromuscular
block were maintained with sevoflurane (1.5–2.5%), and
continuous infusion of sufentanil (0.2–0.3 mg kg21 h21)
and vecuronium (1–2 mg kg21 min21). After induction of
anaesthesia, a 7.0 MHz multiplane probe transoesophageal
echocardiography was inserted to evaluate cardiac function.
Rectal temperature was maintained above 36.08C with
forced warm air blanket, warm mattress, and fluid warmer,
as necessary. Intravascular volume replacement was
managed with crystalloid and colloid solutions to maintain
pulmonary capillary wedge pressure between 8 and 16 mm
Hg according to the baseline values. Norepinephrine (NE, 8
mg ml21) was infused when mean arterial pressure (MAP)
or systolic arterial pressure decreased below 60 or 90 mm
Hg, respectively. Neither corticosteroid nor antifibrinolytics
were used in all patients.
All surgical procedures were performed by one surgeon
(K.J. Yoo) through a median sternotomy and the heart was
displaced using posterior pericardial stitch, large (1270
cm) gauze swabs and was stabilized with tissue stabilizer
(Octopus Tissue Stabilization Systemw, Medtronic Inc.,
USA). Intracoronary shunt (Shunt Floresterw, Bio-Vascular,
USA) was inserted during all grafting procedures of the left
anterior descending artery and distal right coronary artery.
Grafting on other coronary branches was performed with
proximal snare achieving temporary coronary haemostasis.
During the period of heart displacement and grafting, MAP
was maintained above 70 mm Hg with either 10–208
Trendelenburg position, NE infusion, or both. Intraoperative
anticoagulation was achieved using 150 U kg21 of porcine
heparin, with additional dosing administered to maintain
activated clotting time above 300 s during anastomoses, and
was reversed with protamine 0.5 mg per 150 U of heparin.
A cell salvage device (Cell Saverw5þ, Haemonetics, UK)
was used in all cases and salvaged blood was re-infused to
the patient before the end of the surgery. Allogenic packed
red blood cells (pRBCs) were transfused when the haemato-
crit was ,25% for patients 65 yr of age and when the
haematocrit was ,22% for patients ,65 yr of age through-
out the study period. Fresh frozen plasma or platelet con-
centrates were transfused when the INR was .1.5 or the
platelet count ,50 000 mm23 after operation accompanied
with excessive bleeding .200 ml h21 for 2 consecutive
hours, respectively. All patients were transferred to the
intensive care unit (ICU) after surgery.
CRP, IL-6, tumour necrosis factor-a (TNF-a), white
blood cell (WBC) count, percentage of monocyte and neu-
trophil, troponin T (TnT), and CK-MB were measured
before induction of anaesthesia (T0), 4 h after completion
of anastomoses (T2), and on the first and second days after
surgery (T3 and T4, respectively). Serum CRP was
measured using rate immunonephelometry at the insti-
tutional laboratory. Low detection limit of this assay is 0.1
mg dl21 and the intra-assay and inter-assay precision coeffi-
cient of variations range were 3.5–11.1% and 4.0–12.1%,
respectively. The samples for analysis of IL-6 and TNF-a
were placed in ice after collection and then centrifuged
immediately. Afterwards, the serum was separated and
stored frozen at 2708C. IL-6 and TNF-a serum concen-
trations were assayed using enzyme-linked immunosorbent
assay (Quantikinew high-sensitive immunoassay; R&D
Systems, USA). The assay has a detection limit of 0.016
and 0.038 pg ml21 for IL-6 and TNF-a, respectively. The
intra-assay and inter-assay precision coefficient of variations
range for IL-6 were 6.9–7.4% and 6.5–9.6%, and those for
TNF-a were 3.1–8.5% and 7.3–10.6%, respectively. All
blood samples for biochemistry assays were obtained
through the arterial line. Haemodynamic variables including
heart rate, MAP, pulmonary arterial pressure, pulmonary
capillary wedge pressure, central venous pressure, cardiac
index, and right ventricular ejection fraction were recorded
immediately before and after induction of anaesthesia (T0
and T1, respectively), T2, T3, and T4. The corresponding
systemic and pulmonary vascular resistance indices were
also calculated and recorded. The amount of NE infused
during the surgery and the number of patients requiring ino-
tropic agents, amount of salvaged blood, vasodilators, or
NE infused after operation in the ICU was recorded. The
amount of blood loss and transfusion, and fluid balance in
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the operating theatre and ICU were recorded. Postoperative
pain was controlled with i.v. patient-controlled analgesia
with fentanyl in all patients. Additional use of rescue
analgesics, time to extubation, duration of stay in ICU, and
duration of postoperative hospitalization were recorded.
On the basis of our routine maximal CRP serum concen-
tration after OPCAB [15 (SD 7) mg dl21] and the result of
previous study that low dose of ketamine during induction
of anaesthesia reduced CRP serum concentrations about
40–50% after operation compared with values in the
control group,11 a sample size of 22 in each group was
determined with 90% power to detect a 7 mg dl21 differ-
ence in CRP serum concentration between the groups at an
alpha level of 0.05 using independent t-test. In this study,
25 patients in each group were recruited for possible 10–
15% dropouts during the study period. The study was dis-
continued in patients requiring partial aortic cross-clamp in
which the surgeon routinely required infusion of solume-
drol, conversion to on-pump CABG, haemodynamic
instability requiring mechanical support, and reoperation.
Statistical analyses were performed using SPSS 14.0
(SPSS Inc., Chicago, IL, USA). Normality of distribution
was assessed with the q–q plot and the Shapiro–Wilk test.
Parametric data were analysed using the independent t-test
and repeated measures ANOVA followed by post hoc
Dunnett’s test. Non-parametric data were compared using
the Wilcoxon rank-sum test for between the groups and
Friedman’s test for within the groups. Where a difference
was indicated by Friedman’s test, this was further investi-
gated by Mann–Whitney test with the Bonferroni correction
of the resulting P-values. Statistical differences between the
groups were evaluated by x2 test or by Fisher’s exact test
when appropriate. All values were expressed as median
(range), mean (SD), or the number of patients. A P-value of
,0.05 was considered as statistically significant.
Results
All patients enrolled in this study underwent OPCAB suc-
cessfully. Patients’ characteristics were similar between
the groups (Table 1). The amount of midazolam and
sufentanil administered during induction of anaesthesia
was similar between the Control and the Ketamine groups
[2.9 (0.7) vs 3.8 (3.4) mg and 96 (32) vs 100 (26) mg,
respectively] (P¼0.459 and 0.773, respectively). Duration
of surgery, number of grafts and total graft reconstruction
time, and amount of NE infused, salvaged blood, transfu-
sion, and fluid balance in the operating theatre were
similar between the groups (Table 2).
There were no significant differences in the
pro-inflammatory markers’ serum concentrations and
cardiac enzyme concentrations between the groups through-
out the study period. CRP increased significantly compared
with the baseline value in both groups throughout the post-
operative period. IL-6 was highest at T2 and decreased as
time passed after surgery but still higher than the baseline
value in both groups at T4. TNF-a was not significantly
changed in both groups throughout the perioperative period.
The percentage of monocyte decreased significantly com-
pared with the baseline value in both groups throughout the
postoperative period. WBC count, the percentage of neutro-
phil, TnT, and CK-MB significantly increased compared
with the baseline values throughout the postoperative period
in both groups (Fig. 1).
Haemodynamic variables were similar between the
groups (data are not shown). Postoperative data are demon-
strated in Table 3. The number of patients requiring car-
diotonic agents was similar between the groups. The
frequency of treatment with rescue analgesics, time to
extubation, and duration of stay in the ICU and postopera-
tive hospitalization were also similar between the groups.
One patient in each group developed elevation of serum
creatinine concentration (.2.0 mg dl21) after operation
and recovered within 1 week. There were no major com-
plications including major stroke, renal failure requiring
dialysis, cardiac reoperation, prolonged ventilation more
than 48 h, and deep sternal wound infection.
Discussion
This is the first study investigating the anti-inflammatory
effect of low dose of ketamine in low-risk patients
Table 1 Patients’ characteristics. Data are mean (range), mean (SD) or number
of patients. LVEF, left ventricular ejection fraction; ACE, angiotensin-
converting enzyme; ARBs, angiotensin receptor blockers
Factors Control group (n525) Ketamine group (n525)
Age (yr) 64 (50–74) 61 (50–73)
Sex (M/F) 16/9 18/7
Body surface area (m2) 1.7 (0.2) 1.7 (0.2)
LVEF (%) 62.6 (6.7) 62.4 (7.3)
Hypertension 16 17
Diabetes 8 14
Preoperative medication
Calcium channel blocker 12 17
b-blockers 19 17
ACE inhibitors 4 7
ARBs 8 4
Statins 17 23
Table 2 Intraoperative parameters. Data are mean (SD), median (range), or
number of patients. NE, norepinephrine; pRBC, packed red blood cell
Factors Control
(n525)
Ketamine
(n525)
P-value
Duration of surgery (min) 243 (43) 250 (46) 0.550
Number of grafts per patient 3.5 (0.6) 3.3 (0.6) 0.230
Total graft reconstruction time (min) 35 (9) 33 (9) 0.609
Amount of infused NE (mg) 230 (166) 203 (160) 0.581
Amount of salvaged blood (ml) 259 (164) 195 (100) 0.105
Amount of transfused pRBC (ml) 0 (0–750) 0 (0–500) 0.704
Patients transfused with pRBC 9 10 1.000
Amount of i.v. fluid (ml)
Colloid 1291 (252) 1308 (244) 0.835
Crystalloid 3249 (1187) 2675 (892) 0.142
Anti-inflammatory effect of ketamine
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Fig 1 Changes in biological markers. (A) Changes in CRP, (B) IL-6, (C) TNF-a, (D) WBC count, (E) monocyte, (F) neutrophil, (G) TnT, and (H)
CK-MB. Data are expressed as median (min, max) or mean (SD). T0, pre-induction; T2, 4 h after grafting completion; T3, postoperative 1 day; T4,
postoperative 2 day. *P,0.05 compared with values at T0.
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undergoing OPCAB. No significant effect of ketamine on
pro-inflammatory markers’ serum concentrations including
CRP, IL-6, and TNF-a was observed unlike in previous
studies with on-pump CABG.11 12
Since CPB has been recognized as the main cause of
inflammatory activation,4 OPCAB has been expected to
protect patients from complications of systemic inflamma-
tory response. Studies, however, have presented that per-
forming OPCAB may result in reduction, but not in
elimination, of the inflammatory response.8 14 Some
inflammatory markers such as IL-6, IL-8, IL-2R, and CRP
were similarly and significantly activated both in OPCAB
and in on-pump CABG.9 Regarding those results and the
strong association of the inflammatory markers with prog-
nosis,1–3 clinical approaches aimed at reducing periopera-
tive inflammatory response might be beneficial in
improving patient’s outcome after OPCAB.
Ketamine is a non-competitive N-methyl-D-aspartate
receptor antagonist, and in addition to its anaesthetic
activity, the positive immunomodulatory effect of keta-
mine deserves special interest in the case of septic or
cardiac surgical patient.15 Anti-inflammatory effects of
ketamine are thought to be mediated through inhibition of
nuclear factor (NF)-kB, which regulates the transcription
of genes that encode the production of pro-inflammatory
cytokines.16 Indeed, anti-inflammatory effect of ketamine
has been well demonstrated mainly in terms of reducing
the activity of pro-inflammatory mediators, such as CRP,
IL-6, and TNF-a, in most studies.11 17–20 Even a small
dose of ketamine administered during induction of anaes-
thesia significantly attenuated the increase in IL-6 and
CRP in cardiac surgical patients undergoing CPB.11
Therefore, to assess the anti-inflammatory effects of keta-
mine in OPCAB, we measured CRP, IL-6, and TNF-a,
which are all well-established markers of systemic inflam-
mation. In the current trial, ketamine did not significantly
affect the pro-inflammatory mediators’ serum concen-
trations and leucocyte counts.
As this is the first study investigating anti-inflammatory
effects of ketamine in OPCAB, reasons for the discrepan-
cies between the current data and those of the previous
studies in on-pump CABG11 12 are difficult to elucidate. In
addition, other factors possibly affecting the perioperative
inflammatory response such as preoperative medications,
history of diabetes mellitus, perioperative transfusion, and
fluid balance were not clarified in the previous studies
addressing the anti-inflammatory effects of ketamine,11 12
whereas those factors were prospectively controlled and
similar between the groups in this study. Despite these
factors, proposed explanations for the observed lack of
anti-inflammatory effects of ketamine in this study are as
follows. First, considering that the protective anti-
inflammatory effect of ketamine was presented to be
different according to the degree of injury and inflamma-
tory activation,21 less activation of inflammatory reaction
after OPCAB would be the most responsible cause for the
distinguished result of the current study. Furthermore, to
avoid the introduction of confounders, we had only
enrolled low-risk patients with preserved LVEF and stable
angina, thus the observed activation of innate immunity
with its pro-inflammatory markers seems to be controlled
or adaptive. Indeed, the increase in CRP and TNF-a con-
centration in this study was notably lower in both groups
than those of previous studies.8 11 22 23 Secondly, differ-
ences in anaesthetic agents could also have contributed to
the results. In contrast to the previous studies in which
fentanyl was the main anaesthetic agent, sevoflurane was
the main anaesthetic agent in this study. Volatile anaes-
thetics have dose-dependent inhibitory effects on neutro-
phil functions and suppress cytokine release in contrast to
synthetic opioid which has minimal effects on immunity.24
Thirdly, most of the patients were on statin therapy before
the surgery in this study, which has been reported to exert
significant anti-inflammatory effects in cardiac surgical
patients.25 Although there is currently no evidence regard-
ing the anti-inflammatory effects of statin in OPCAB and
the number of patients treated with statin was similar
between the groups, the resultant attenuation and modifi-
cation of the overall inflammatory activity could have con-
tributed to the observed lack of anti-inflammatory effect of
ketamine in this study.
The dose of ketamine in this study was decided accord-
ing to the report that 0.5 mg kg21 of ketamine attenuated
increase in CRP and IL-6 after CPB.11 Since anti-
inflammatory effect of ketamine is dose-related,26 higher
dose of ketamine could have attenuated inflammatory reac-
tions in OPCAB. It should be considered that a larger dose
of ketamine can elicit adverse haemodynamic modifi-
cations towards an increase in myocardial oxygen con-
sumption,27 since ketamine produces a dose-related
increase in cardiovascular stimulation.
The limitation of this study is as follows. We did not
assess anti-inflammatory mediators such as IL-10, which
also has been presented to block the activity of NF-kB,28
Table 3 Postoperative data. Data are mean (SD), median (range), or number of
patients. Cr, creatinine; pRBC, packed red blood cell; ICU, intensive care unit
Factors Control
(n525)
Ketamine
(n525)
P-value
Patients treated with
Norepinephrine 15 20 0.217
Nicardipine 16 12 0.393
Nitroprusside 8 8 1.000
Milrinone 1 4 0.349
Frequency of additive analgesics 2.5 (2.0) 2.6 (4.2) 0.932
Patients with Cr .2.0 mg dl21 1 1 1.000
Amount of transfused pRBC (ml) 0 (0–1120) 0 (0–1000) 0.647
Patients transfused with pRBC 7 9 0.762
Amount of i.v. fluid (ml)
Colloid 77 (123) 122 (154) 0.257
Crystalloid 1543 (629) 1574 (485) 0.847
Time to extubation (min) 831 (234) 875 (251) 0.570
ICU day (day) 3.0 (0.7) 3.0 (0.4) 1.000
Hospital day (day) 14.4 (2.9) 13.2 (4.0) 0.212
Anti-inflammatory effect of ketamine
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therefore could not assess any effects of ketamine on the
anti-inflammatory mediators. Conflicting results have been
reported regarding the ketamine’s effect on the anti-
inflammatory mediators, and although low-dose ketamine
was reported to attenuate increases in IL-10 in OPCAB,11
other studies have failed to demonstrate any effects on the
anti-inflammatory mediators.29 30
In conclusion, low dose of ketamine administered
during induction of anaesthesia could not reduce CRP,
IL-6, and TNF-a serum concentration in low-risk patients
undergoing OPCAB.
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